Steriline Srl: Expanding its footprint in South India
India has become Steriline’s biggest and most important market in just a few decades, with an installed base of 100+ filling lines comprising 800+ machines alone in the country.
Steriline Srl, an Italian manufacturer founded in 1989 near Lake Como, is a leading global supplier of complete aseptic processing lines for injectable pharmaceutical products. The company specializes in robotic and traditional filling lines for vials, ampoules, cartridges, and syringes, serving pharmaceutical companies across 50+ countries. Steriline is committed to provide customers reliable solutions for improved efficiency, consistent quality and enhanced safety across the sector.
Steriline Asia Private Limited
In June 2023, Steriline Srl partnered with Indian agent INCOME to create Steriline Asia Private Limited, a subsidiary headquartered in Mumbai, Maharashtra:
South India Connection
While the subsidiary is Mumbai-based (West India), Steriline Asia maintains support offices in regional cities across India and actively serves the PAN India market, including South India’s major pharmaceutical hubs (i.e. Hyderabad, Bangalore, Chennai, Vizag). The company’s direct manufacturer-customer relationship has strengthened trust with Asian customers, making service more accessible “at customers’ doorstep”.
Interview with Chiranjeevi Kondapaka, Chief Executive Officer of Steriline Asia
In an exclusive interview with Pharma Machines & Technology, Chiranjeevi Kondapaka, Chief Executive Officer of Steriline Asia, speaks on various topics…
Q. Could you highlight recent advancements in Steriline’s robotic and mechanical solutions that align with sustainable production goals?
Steriline’s recent innovations in robotic and mechanical solutions not only enhance production efficiency but also significantly contribute to sustainability goals within the pharmaceutical industry. By focusing on waste reduction, resource optimization, and compliance, Steriline is positioning itself as a leader in sustainable pharmaceutical manufacturing practices.
Q. Steriline emphasizes collaboration with regulatory bodies for innovation. How does this partnership influence the development of new aseptic processing technologies?
Through its close collaboration with regulatory bodies, Steriline ensures that its technologies comply with Good Manufacturing Practice (GMP) regulations. This compliance is essential for maintaining the safety of sensitive medications. The introduction of advanced monitoring systems and sterilization technologies further enhances product safety while meeting evolving regulatory requirements.
Q. Steriline’s hybrid production lines offer flexibility and efficiency. Can you provide insights into how these lines are impacting the Indian pharmaceutical industry?
Steriline’s hybrid production lines are making a substantial impact on the Indian pharmaceutical industry by providing flexibility, efficiency, and compliance with regulatory standards. These advantages not only enhance operational capabilities but also enable manufacturers to respond effectively to market changes and consumer demands. As the industry continues to evolve, Steriline’s innovative solutions will likely play a crucial role in shaping the future of aseptic processing in India.
Q. How is Steriline Asia positioning itself to remain competitive and agile in a rapidly changing market?
Being “just an arm’s length away” from customers improves confidence and support systems. This local presence enables Steriline to respond promptly to customer needs and market changes, enhancing service delivery and satisfaction.
Q. Looking ahead, what innovations or strategic initiatives can we expect from Steriline Asia in the near future?
In summary, Steriline Asia’s future initiatives will focus on enhancing flexibility in production lines, committing to sustainability, integrating advanced technologies, establishing local manufacturing capabilities, and actively participating in industry discussions. These strategic moves are aimed at making medicines more accessible and efficient while positioning Steriline as a leader in the rapidly evolving pharmaceutical landscape in India and beyond.